Hardesty Lab

About 

The Hardesty laboratory is focused on identifying mechanisms of compromised liver regeneration and treatment options that restore liver regeneration and liver function in alcohol-associated liver disease (ALD) and metabolic dysfunction associated steatotic liver disease (MASLD). Liver diseases are thought to persist due to chronic inflammation that goes unresolved preventing liver regeneration. This is a common feature in multiple end-stage liver diseases for which there are no adequate treatments or therapies.

Key Research Areas

  • Mechanisms of compromised liver regeneration in ALD and MASLD and the identification of therapies.
  • Mechanisms of impaired liver function in ALD and MASLD and the identification of therapies.
  • Identify markers and mechanisms of corticosteroid non-responsiveness in alcohol-associated hepatitis.
  • Develop and utilize Visium Spatial Transcriptomic approaches to study liver pathology to identify novel cell types and transcriptomic signatures.
  • Use a health-centric approach to identify novel therapeutics targets for MASLD.
  • Investigate mitochondrial aberrations in end stage liver diseases.

Recent Publications

View Hardesty Lab Github Page

Team 

Hardesty Lab

Department of Pharmacology & Toxicology

Website about

Phone

Location

Clinical Translational Research Building

505 South Hancock St., Lab: Room 527F, Office: Room 522